ES2091307T3 - Asociaciones de vacunas contra los patogenos infecciosos. - Google Patents

Asociaciones de vacunas contra los patogenos infecciosos.

Info

Publication number
ES2091307T3
ES2091307T3 ES91400513T ES91400513T ES2091307T3 ES 2091307 T3 ES2091307 T3 ES 2091307T3 ES 91400513 T ES91400513 T ES 91400513T ES 91400513 T ES91400513 T ES 91400513T ES 2091307 T3 ES2091307 T3 ES 2091307T3
Authority
ES
Spain
Prior art keywords
virus
pathogen
associations
vaccines against
aforementioned
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91400513T
Other languages
English (en)
Inventor
Patrick Biront
Maurice Pensaert
Joris Vandeputte
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Animal Health France SAS
Original Assignee
Rhone Merieux SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9400808&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2091307(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Rhone Merieux SA filed Critical Rhone Merieux SA
Application granted granted Critical
Publication of ES2091307T3 publication Critical patent/ES2091307T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)

Abstract

LA ASOCIACION VACCINEA DIRIGIDA CONTRA UN PATOGENO, POR EJEMPLO UN VIRUS DE LA FAMILIA DE LOS HERPES-VIRUS ANIMALES O HUMANOS COMPRENDE UNA PRIMERA VALENCIA QUE COMPRENDE DICHO PATOGENO O VIRUS EN ESTADO VIVO ATENUADO O UN RECOMBINANTE QUE EXPRESA GLICOPROTEINAS ANTIGENICAS DE DICHO PATOGENO O VIRUS Y UNA SEGUNDA VALENCIA QUE COMPRENDE GLICOPROTEINAS DE ENVOLTURA O DE PARED ANTIGENICAS DE DICHO PATOGENO O VIRUS. LAS DOS VALENCIAS PUEDEN ESTAR BIEN MEZCLADAS LISTAS PARA SU USO, BIEN PARA MEZCLAR DE MANERA EXTEMPORENA, BIEN SEPARADAS PARA UNA ADMINISTRACION SIMULTANEA Y SEPARADA.
ES91400513T 1990-10-01 1991-02-26 Asociaciones de vacunas contra los patogenos infecciosos. Expired - Lifetime ES2091307T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9012073A FR2667245B1 (fr) 1990-10-01 1990-10-01 Association vaccinale contre les pathogenes infectieux.

Publications (1)

Publication Number Publication Date
ES2091307T3 true ES2091307T3 (es) 1996-11-01

Family

ID=9400808

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91400513T Expired - Lifetime ES2091307T3 (es) 1990-10-01 1991-02-26 Asociaciones de vacunas contra los patogenos infecciosos.

Country Status (8)

Country Link
EP (1) EP0479627B1 (es)
JP (1) JPH0687759A (es)
KR (1) KR920007636A (es)
AT (1) ATE140153T1 (es)
CA (1) CA2052459A1 (es)
DE (1) DE69120761T2 (es)
ES (1) ES2091307T3 (es)
FR (1) FR2667245B1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5976552A (en) * 1995-04-28 1999-11-02 Protein Sciences Corporation Virus vaccines
ZA978434B (en) * 1996-09-27 1998-03-26 Akzo Nobel Nv Inactivated vaccines.
WO1998046262A1 (en) * 1997-04-16 1998-10-22 Connaught Laboratories, Inc. Anti-influenza compositions supplemented with neuraminidase

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE116860T1 (de) * 1988-08-01 1995-01-15 Akzo Nobel Nv Pseudorabiesvirus-impfstoff.

Also Published As

Publication number Publication date
JPH0687759A (ja) 1994-03-29
ATE140153T1 (de) 1996-07-15
FR2667245A1 (fr) 1992-04-03
FR2667245B1 (fr) 1992-11-06
EP0479627B1 (fr) 1996-07-10
CA2052459A1 (en) 1992-04-02
DE69120761T2 (de) 1996-12-12
EP0479627A1 (fr) 1992-04-08
KR920007636A (ko) 1992-05-27
DE69120761D1 (de) 1996-08-14

Similar Documents

Publication Publication Date Title
HUT69803A (en) Porcine reproductive respiratory syndrome vaccine and diagnostic
MY111880A (en) Hepatitis vaccines containing 3-0 deacylated monophosphoryl lipid a
MX9302982A (es) Composicion de vacuna que incluye componente de vacuna de la hepatitis b, para el tratamiento de infecciones por hepatitis b.
MY110086A (en) Herpes simplex virus vaccines comrpising glycoprotein d and 3d-mpl
LU91323I2 (fr) Vaccin papillomavirus humain Ätypes 6,11,16,18Ü(recombinant, adsorbé).-silgard
IL130075A0 (en) A vaccine for eliciting an immune response to an antigen in an animal
ATE179614T1 (de) Herpes simplex virus vp16 impfstoffe
FI931393A7 (fi) Peptidit käytettäväksi rokotuksessa ja neutraloivien vasta-aineiden in duktiossa ihmisen immuunikadon aiheuttavaa virusta vastaan
DE3071594D1 (en) Feline infectious peritonitis virus, its preparation and vaccines containing it
TW377373B (en) Recombinant raccoon pox viruses and their use as an effective vaccine against feline infectious peritonitis virus disease
BR9704879A (pt) Composição de vacina e uso de um vírus cav vivo
TW340873B (en) Chicken anaemia agent vaccine
NZ183907A (en) Attenuated live equine herpes i (equine rhinopneumonitis) virus and vaccine
ES2091307T3 (es) Asociaciones de vacunas contra los patogenos infecciosos.
CA961410A (en) Live attenuated infectious bovine rhinotracheitis virus vaccines and preparation thereof
GR3014952T3 (en) Use of an immunoglobulin-containing composition in the prophylaxis and therapy of AIDS of human.
IL60370A0 (en) Polyvalent virus vaccine and its preparation
WO1999056772A3 (en) Hepatitis vaccine
FR2385401A1 (fr) Vaccin a virus respiratoire syncytial
PT636030E (pt) Vacina de bacterina-toxoide de pasteurella haemolytica tipo a-1
ES2074965B1 (es) Virus mutante recombinante de rinotraqueitis infecciosa bovina y vacunas que lo contienen.
MC2306A1 (fr) Peptides bloquant les infections par le virus de l'immunodeficience humaine et methode de leur utilisation
JPS6471488A (en) Preparation of human immunodeficient virus type i antigen, and its use as diagnostic and curing agents
SU1565027A1 (ru) Инактиватор вируса западного нила

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 479627

Country of ref document: ES